Lysine methylation: Implications in neurodegenerative disease

Area of Science:

• Biochemistry
• Epigenetics
• Neuroscience

Background:

• Lysine methylation of histones regulates gene expression via lysine methyltransferases (KMTs) and lysine demethylases (KDMs).
• This epigenetic mechanism is extensively studied for its role in neurological diseases.
• Recent discoveries reveal non-histone protein substrates for KMTs, expanding the scope of lysine methylation research.

Purpose of the Study:

• To review the role of histone lysine methylation in neurodegenerative diseases.
• To explore the connection between non-histone protein methylation and brain function.
• To bridge the emerging field of non-histone protein methylation with neurodegenerative disease research.

Main Methods:

• Literature review of histone and non-histone lysine methylation.
• Analysis of studies linking KMTs and KDMs to neurodegenerative processes.
• Synthesis of current research on non-histone substrates in the context of brain health.

Main Results:

• Histone lysine methylation is a known factor in neurodegenerative disease pathogenesis.
• Non-histone protein methylation influences critical cellular processes like signal transduction and apoptosis.
• Evidence suggests non-histone methylation may also play a role in neurodegeneration, similar to its role in cancer.

Conclusions:

• Lysine methylation is a dynamic post-translational modification with significant implications for cellular function.
• The role of non-histone protein methylation in the brain and its relevance to neurodegenerative diseases warrants further investigation.
• Connecting non-histone protein methylation to neurodegeneration offers a novel research avenue.